AVEC caused massive necrosis of all HER-2+ ovarian cancer cells in the percentages, which were statistically significantly much higher than those inflicted by naked trastuzumab and biosimilars (Fig. 4d). Here, ERBB2 is linked to ovarian carcinoma.